GMD 4c
Latest Information Update: 23 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Heat-shock protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 Apr 2000 New profile
- 14 Apr 2000 Preclinical development for Cancer in USA (Unknown route)